Venture Capital LPs: AI Bets, Pacing and Risk
See why venture LPs are backing overlapping AI bets, what faster fund cycles signal, and how secondaries and emerging managers are changing the risk equation.
Venture Capital LPs: AI Bets, Pacing and Risk
Why Venture Investors Are Doubling Down on the Same AI Companies
Limited partners (LPs) usually diversify across venture firms, managers, and strategies. The idea is simple: in venture, a small number of companies often drive most of the upside, so spreading bets can reduce the risk that any one outcome goes sideways.
In this AI cycle, though, it's getting harder to pretend portfolios are truly different. Many venture funds are increasingly converging on the same names - especially OpenAI and Anthropic.
So far, LPs seem willing to live with that concentration. The upside is real: some AI companies are growing revenues faster than what many earlier venture cycles saw. But the backdrop is unusual. Funds are moving faster, managers are raising more frequently, and liquidity options for private companies are changing while valuations remain elevated.
The real question isn't just whether AI is a compelling opportunity. It's whether the way venture capital is being allocated can hold up if market conditions shift. Beezer Clarkson (LGT Capital Partners) and Amit Bhatti (TrueBridge) put a helpful frame around it: concentration can be normal in venture returns, but the speed of that concentration is worth questioning.
This piece looks at why LPs are accepting overlapping bets, how to evaluate faster fund pacing, what secondaries change, and what this market moment means for emerging managers.
Why are venture portfolios concentrating in AI companies
Venture returns are uneven by design. A small number of companies can account for a big chunk of a fund's performance, while many investments return little or nothing. That's why some LPs don't automatically treat portfolios that eventually consolidate into a few winners as a problem. In mature funds, it's common for companies like Databricks, SpaceX, or Stripe to end up carrying much of the outcome.
The current AI cycle follows the same basic logic, just on a faster timeline. Multiple venture firms and funds have backed OpenAI and Anthropic, and that exposure shows up repeatedly across an LP's portfolio. The result: the diversification an LP thinks it has isn't as complete as it looks when you only compare managers side by side.
Concentration is not the same as a bad portfolio
A concentrated portfolio can outperform if the biggest companies keep increasing in value and ultimately return capital. And diversification across managers doesn't automatically mean diversification across the underlying companies. If several managers own the same private company, the LP still ends up with correlated exposure - even if each fund has a different strategy or vintage.
This overlap can make sense when the companies are unusually strong and access is limited. It's also different from simply piling money into speculative businesses that haven't shown traction. In interviews, the LPs described seeing some AI companies move from minimal or no revenue to meaningful revenue. That changes how investors compare today's cycle with earlier periods of rapid investment.
But revenue growth doesn't remove risk. Private valuations can move ahead of fundamentals, and revenue alone doesn't tell you whether margins hold, the company defends its position, or growth turns into durable cash generation. The investment case still depends on price, ownership, future financing needs, and eventual liquidity.
The speed of convergence matters
Here's the distinction that keeps coming up: where portfolios end up versus how quickly they get there. A fund that gradually concentrates around a few proven winners over a decade isn't the same thing as a fund that sends a large share of its capital into a small number of companies within a year.
LPs may accept concentrated exposure, but they still need a clear view of total position across all their venture funds. That typically means asking:
- How much exposure do all the LP's venture funds have to the same company?
- What share of each fund is tied up in that position?
- Is the company's valuation and financing need moving faster than the business fundamentals?
- How much capital is left for other opportunities and follow-on rounds?
Looking at the portfolio as a whole is more useful than deciding concentration is either inherently good or inherently reckless. The portfolio-level view helps you see whether investments that looked defensible on their own have quietly combined into a risk the LP didn't intend to take.
Is faster venture fund pacing a warning sign
Venture funds have historically deployed capital over several years. In interviews, LPs described a shift for some managers from roughly two-to-three-year investment periods toward 12-to-18-month cycles. Some funds have also increased their fund size mid-cycle to participate in larger financing rounds.
Moving faster isn't automatically evidence of bad judgment. If a company raises a very large round, a manager may need to commit more capital to maintain a meaningful ownership position. Seed rounds have also grown, so a fund that wants to lead may write bigger checks than it would have a few years ago.
Still, pacing changes the decision environment. A shorter window can mean less time to evaluate companies, build the portfolio, and react to new information. It can also create pressure to commit capital before the original plan has been truly stress-tested.
Separate market demand from fund discipline
When an LP sees faster deployment, the first job is to understand why. There's a big difference between a manager investing quickly because a small set of exceptional deals clearly fit its thesis, and a manager accelerating simply because large rounds happen to be available.
A good review should cover:
- The original plan: What schedule did the manager expect, and how did it plan to keep reserves?
- The change: Which rounds, company needs, or fund-size adjustments pushed spending faster?
- Portfolio construction: How much is going to new investments versus follow-ons?
- Decision quality: Did underwriting stay consistent as checks got larger?
- Future capacity: Does the fund still have reserves for companies that need more capital?
This isn't about forcing the same pacing rule onto every firm. A specialist with strong access to a narrow set of opportunities will likely invest at a different rhythm than a broad early-stage fund. The real question is whether the revised pace still matches the strategy - and whether the manager can explain the trade-offs clearly.
Fundraising cadence creates pressure on both sides
LPs aren't the only ones who feel pressure when cycles speed up. Rapidly returning to market is hard for LPs and GPs alike. Many institutions plan commitments around a calendar. They also have operating obligations, and capital calls keep coming even when distributions are slow.
On top of that, an LP may want to support a manager but not have the flexibility to make the same commitment every year. Skipping a fund can be costly, too. If a manager's best outcomes are tied to a small number of top-performing funds, missing one vintage may mean losing access to a future winner. In practice, LPs may reduce commitments instead of exiting completely, or they may agree on a schedule that matches their own capital plan.
For GPs, raising an existing fund can look easier than launching a new one. But a larger fund changes the return hurdle and can affect how much ownership the manager needs to buy. Fund size isn't just a fundraising win - it becomes a constraint on future investment choices.
So the warning sign isn't simply "short cycle." It's short cycle plus unclear underwriting, larger fund size, and limited discussion of reserves or how the portfolio will be built.
How are secondaries changing venture liquidity
For years, venture liquidity usually meant an IPO or an acquisition. Secondary transactions add another route: existing shares can be sold to another investor before the company lists or gets bought. Today, secondaries can show up at multiple levels - employees selling shares, venture funds selling parts of a position, and LPs selling interests in funds or portfolios.
That wider set of options can make venture portfolios easier to manage. Venture investing is long-duration by nature, and waiting many years for a public exit can strain funds, employees, and institutions that need some capital back. A functioning secondary market can create partial liquidity without forcing the company to go public.
Partial sales can balance conviction and risk
Selling part of a position doesn't automatically mean you're abandoning the thesis. If a fund still thinks the company can become a major outcome, it may keep most of its shares while selling a portion to return capital or reduce concentration. Sometimes that looks like selling a minority stake rather than exiting the company entirely.
That said, it's not a universal rule. The "right" amount depends on the fund's ownership level, the company's prospects, the price being offered, how long the fund has left, and how the fund needs to distribute proceeds. A sale at an attractive price can improve fund-level liquidity - but selling too early can hurt returns if the company's value keeps climbing.
Secondaries also need careful interpretation. A transaction price isn't automatically a reliable measure of what a company is truly worth. The terms, share class, restrictions, and size of the transaction all matter. A small sale under specific conditions may not be comparable to a large primary financing round where new money enters the cap table.
Employee liquidity has a different purpose
Employee tenders can let people capture some value from their equity without leaving the company. That can be reasonable for established businesses with clearer financials, especially when employees have held illiquid shares for years. Partial liquidity can reduce personal financial pressure while keeping an incentive to stay.
The risk is timing. If liquidity arrives too early - or becomes so large that it weakens the link between future performance and rewards - then it can distort incentives. Venture investors often describe it as a governance issue that depends on lead investors and the founder's negotiating power. A tender isn't just a financial transaction. It can affect retention, expectations, and company culture.
The broader ecosystem has also learned from earlier periods when employees received assets that could be sold immediately. If employees can realize meaningful value before the company encounters tougher operating conditions, incentives may shift. That doesn't mean employee sales are inherently wrong. It just means the size, timing, and structure of the deal matter.
For LPs, the key development is that liquidity is no longer limited to IPOs and acquisitions. Secondaries add flexibility - but they don't remove the need to judge the underlying company and the price paid for its shares.
What should LPs and emerging managers do next
This market isn't just a binary choice between big, established funds and small, first-time managers. LPs still back emerging firms, but fundraising is tougher and fund sizes are often smaller. A first fund might focus on a tight strategy and a modest pool of capital, rather than trying to compete immediately with the largest platforms.
For an emerging manager, that can be an advantage when the fund size matches the opportunity. Smaller funds can work well for early-stage strategies where access, selection, and ownership matter more than writing the largest check. It also gives a new GP room to prove judgment before raising a much larger vehicle.
What LPs should test before committing
A practical LP review has to go beyond a manager's brand or access to popular AI companies. The real questions are whether the manager can run a repeatable investment process and whether the fund fits into the LP's overall portfolio.
- Thesis: Is the reason for investing specific enough to guide both selection and follow-ons?
- Access: Can the manager consistently reach the companies it wants to back?
- Judgment: What evidence shows the manager can separate strong opportunities from crowded ones?
- Fund size: Does the money being raised match the strategy, stage, and expected ownership?
- Portfolio overlap: How does this fund change the LP's exposure to shared companies?
- Capital plan: Can the LP meet commitments and capital calls if the manager raises more often?
- Liquidity assumptions: Does the plan rely entirely on IPOs, or can the fund handle partial exits and longer holding periods?
These questions change depending on fund stage. Early-stage managers often have broader outcome distributions and smaller initial checks. Late-stage strategies that concentrate in a few large companies need extra scrutiny around valuation, follow-on needs, and correlated exposure.
What emerging managers should prove
Not every emerging GP fits a single mold. Some are experienced investors leaving established firms. Others are operators, founders, or angel investors building a formal vehicle. Some may even keep operating a company while investing.
LPs may be open to these setups, but flexibility doesn't replace evidence. A new manager should be able to show how it sources deals, makes decisions, and earns access to competitive rounds. A small fund can be a credible start if it has a clear thesis and disciplined execution. Trying to raise a much larger first fund can make things harder. The GP has to find enough suitable investments, maintain ownership, and manage reserves without diluting the strategy.
Concentration also matters to the GP. If one investor supplies a large share of the fund, it can help close the vehicle - but it can also create dependence and make future fundraising more difficult. Some LPs therefore encourage managers to diversify their investor base, even when they're willing to anchor the fund.
Key takeaways
- Overlapping exposure to leading AI companies can be rational, but LPs should measure it across the full portfolio.
- Faster deployment deserves scrutiny when it comes with bigger funds or unclear changes to the investment plan.
- Secondaries can expand liquidity options, but they don't guarantee a fair price or a clean exit.
- Emerging managers can compete with smaller funds when their strategy, access, and judgment are genuinely distinct.
- The core test is fit: fund size, pace, and concentration should match the manager's strategy and the LP's ability to fund it.
Conclusion
Today's venture market mixes familiar dynamics with a noticeable twist: speed. Concentration in a few major companies is consistent with venture's power-law outcomes, but the pace at which funds are building exposure raises a separate question about discipline and portfolio construction.
LPs don't need to shut the door on AI exposure, and they don't need a single pacing rule for every manager. They do need to understand their total exposure, test why deployment accelerated, and plan for capital calls and liquidity under different market conditions. GPs, meanwhile, need fund sizes and investment schedules that fit their strategy - not just whatever momentum the fundraising market is showing.
The most useful stance is neither panic nor passive optimism. Treat concentration as a portfolio fact, treat speed as a signal to dig in, and treat liquidity as a tool with real trade-offs. That's how you tell the difference between a compelling opportunity and a process that only works while valuations keep rising.